We are an internationally approved and recognised medical device that is proud to show our certifications.
Registered by the Australian Governments Therapeutic Goods Association (TGA).
Turboforte meets the European Union's (EU) standards for health, safety, and environmental protection.
Using the latest in medical innovation, we’ve created an answer for clearer, healthier and stronger lungs – all in one small but powerful package.
Turboforte Lung Physio and other similar flutter valve devices have participated in many clinical trials, and have also undertaken rigorous testing in many hospitals and universities world-wide. Below is a representation of a few of the completed studies.
Study Oscillatory Positive Expiratory Pressure in Chronic Obstructive Pulmonary Disease Finding “In COPD patients with chronic sputum production, PEQ and SGRQ scores, FVC and 6MWD
Study Noncystic Fibrosis Bronchiectasis: Regional Abnormalities and Response to Airway Clearance Therapy Using Pulmonary Functional Magnetic Resonance Imaging Finding “There was CT and MRI evidence
Study OPEP in lower respiratory tract infections Finding “In conclusion, OPEP exhibited a greater effectiveness in draining sputum, improving oxygenation and reducing inflammatory status in
Study A Functional Respiratory Imaging Approach to the Effect of an Oscillating Positive Expiratory Pressure Device in Chronic Obstructive Pulmonary Disease Finding “ The utilization
Study Oscillating Positive Expiratory Pressure on Respiratory Resistance in Chronic Obstructive Pulmonary Disease With a Small Amount of Secretion: A Randomized Clinical Trial Finding “The
Study Effects of an Airway Clearance Device on Inflammation, Bacteriology, and Mucus Transport in Bronchiectasis Finding “The use of a flutter valve for 30 min/d
Study Effects of an Airway Clearance Device on Inflammation, Bacteriology, and Mucus Transport in Bronchiectasis Finding “ Adjunctive therapy with a PEP device versus standard
